Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). but the effectiveness of this monotherapy is still very low. A possible mechanism of resistance to hypomethylating agents (HMAs) is the upregulation of the expression of inhibitory ch... https://www.lightemupsequences.com/top-offer-SALE-Skylight-Quilt-PATTERN-P173-by-Fran-Gulick-Riley-Blake-INSTRUCTIONS-Only-Confident-Beginner-Precut-Friendly-Mult-super-offer/